AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ontramab 440mg Injection

Prescription Icon
Prescription Required

Marketer

Celon Laboratories Ltd

Salt Composition

Trastuzumab (440mg)

Overview Ontramab 440mg Injection

Herceptin-equivalent Ontramab 440mg Injection combats breast and gastric cancers by targeting and eliminating HER2-positive cells. Administered intravenously by a healthcare professional, the dosage and frequency are individually determined by your physician based on your condition, potentially adjusting over time. Precise adherence to your doctor's instructions is crucial, as incorrect usage or overdose can lead to severe complications. Therapeutic effects may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. Ontramab can lower blood cell counts, raising infection susceptibility. Regular blood work monitoring blood cell levels, heart function, liver health, and uric acid is essential. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is vital throughout treatment.

Primary Ingredients of Ontramab 440mg Injection

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Ontramab 440mg Injection

Malignancies affecting the mammary glands and stomach.

Major Benefits of Ontramab 440mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Ontramab 440mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Ontramab 440mg Injection:

Administering this medication will be handled by your physician or their qualified nurse; self-medication is strictly prohibited.

How Ontramab 440mg Injection works:

The injectable medication Ontramab (440mg) is a genetically engineered IgG1 monoclonal antibody that targets HER2, the human epidermal growth factor receptor 2 protein. By binding to HER2 receptors, it prevents the excessive growth of breast and gastric cancer cells. This action halts the HER2-driven proliferation and disrupts several downstream signaling cascades implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Ontramab 440mg Injection and alcohol can result in significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Ontramab 440mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Ontramab 440mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Ontramab 440mg Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of 440mg Ontramab Injection in patients with renal impairment is likely safe, with current evidence indicating dose modification may be unnecessary. However, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the administration of 440mg Ontramab Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Ontramab 440mg Injection :

Omit a dose of Ontramab 440mg Injection? Seek your physician's advice.

Facts to Know About Ontramab 440mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Type of Therapy Cancer Medications
Actions Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Ontramab 440mg Injection

Ontramab 440mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea, vomiting, loss of appetite, rapid heartbeat, urine discoloration, decreased or painful urination, difficulty urinating, and signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception must be used by women of childbearing age throughout Ontramab 440mg Injection therapy and for seven months afterward. Pregnancy may be planned seven months after completing Ontramab 440mg Injection treatment.
Early-stage breast cancer patients should receive Ontramab 440mg Injection for one year, or until disease recurrence, whichever comes first; treatment should not exceed one year.
Ontramab 440mg Injection does not require fasting beforehand. Administration must be supervised by a physician experienced in cancer chemotherapy and performed only by a qualified healthcare professional.
Ontramab 440mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the label to administer the prescribed formulation; IV Ontramab is for intravenous infusion only. Your doctor may change your treatment between IV and SC Ontramab if clinically appropriate.
Ontramab 440mg Injection is a monoclonal antibody targeting the HER2 protein, found on the surface of some cancer cells. It inhibits cancer cell growth and spread by binding to HER2. Consequently, this injection is only effective, and therefore indicated, for patients with HER2-positive cancer; it's ineffective in HER2-negative cases.
Using Ontramab 440mg Injection with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations should begin at treatment initiation, continue every three months throughout treatment, and then every six months post-treatment for up to 24 months following the final Ontramab 440mg Injection. Patients with pre-existing cardiac conditions require evaluations every 12 weeks.
Ontramab 440mg Injection
27,216
MRP 30,000
9% off